The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
Scholars, analysts, and companies cannot agree on what Amgen v. Sanofi means for patients, drug makers, and innovation.

Scholars, analysts, and companies cannot agree on what Amgen v. Sanofi means for patients, drug makers, and innovation.
Legal authority suggests that the Constitution does not clearly prohibit a state from regulating abortion travel.
During the COVID-19 federal public health emergency, the sovereignty of the Native American Nations to protect their citizens was essential.
The public health establishment should take stock of itself and commit to better targeted and clearly justified employment of legal force.
The most promising path forward in public health is to continue recognizing federal authority and responsibility in this space.
Older federal health laws are on a downward spiral to address modern health problems, but the spiraling can reversed — if Congress acts.
Most doctors want a federal medical license. But would the Constitution allow Congress to control accreditation?
The consequences that result from state bans and restrictions on medication abortion represent just one example of “healthcare federalism.”